ImmuCell Corporation (ICCC) Financials
ICCC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 44.5 million | 18.5 million |
| 2023-06-30 | 44.0 million | 17.2 million |
| 2023-03-31 | 43.1 million | 15.0 million |
| 2022-12-31 | 44.9 million | 14.5 million |
ICCC Free Cash Flow and Stock based compensation
No data available :(
ICCC Net Income
No data available :(
ICCC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 2.0 million | - | 4.4 million |
| 2023-06-30 | 1.5 million | 8.6 million | 4.4 million |
| 2023-03-31 | 3.1 million | 8.9 million | 2.2 million |
| 2022-12-31 | 5.8 million | - | 2.2 million |
ICCC Shares Outstanding
ICCC Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 420515 | 1.1 million | 514952 | 817486 |
| 2023-06-30 | 708488 | 1.1 million | 529056 | 719789 |
| 2023-03-31 | 682166 | 1.1 million | 567019 | 879427 |
| 2022-12-31 | 1.5 million | 1.0 million | 583966 | 3.3 million |
ICCC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 5.4 million | 4.1 million |
| 2023-06-30 | 3.5 million | 2.5 million |
| 2023-03-31 | 3.4 million | 3.1 million |
| 2022-12-31 | 3.9 million | 2.9 million |
ICCC
Price: $5.03
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.75 USD
P/E Ratio: -6.41
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 8519
Ebitda: 1.2 millionMarket Capitalization: 40.1 million